Accessing utility of immunohistochemistry, PD-L1 correlation with stage of cancer and EGFR mutation with disease survival in primary lung carcinoma
Abstract Background Accurate non-small cell lung carcinoma (NSCLC) typing is crucial for targeted therapy selection. This study investigates how immunohistochemistry (IHC) can improve early diagnosis and molecular categorization of NSCLC. Additionally, we explore the relationship between epidermal g...
Saved in:
| Main Authors: | Kartavya Kumar Verma, Amit Bugalia, Ajoy Kumar behera, Nighat Hussain |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Surgical and Experimental Pathology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42047-025-00190-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between PD-L1 expression with EGFR, ALK, and ROS1 driver oncogene mutations in non-small cell lung cancer
by: Dülger Onur, et al.
Published: (2025-01-01) -
Investigating the correlation between IDO1/PD-L1 expression or co-expression and EGFR/KRAS gene mutations in advanced NSCLC
by: Zhidong Yin, et al.
Published: (2025-08-01) -
The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative radiotherapy in stage III-pN2 NSCLC
by: Jinquan Yao, et al.
Published: (2025-05-01) -
A Multispecific Checkpoint Inhibitor Nanofitin with a Fast Tumor Accumulation Property and Anti-Tumor Activity in Immune Competent Mice
by: Perrine Jacquot, et al.
Published: (2025-03-01) -
The Potential Role of sPD-L1 as a Predictive Biomarker in EGFR-Positive Non-Small-Cell Lung Cancer
by: Vesna Ćeriman Krstić, et al.
Published: (2025-01-01)